• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    2.15 Up 0.04(1.90%) Sep 4, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.11
    Open:2.06
    Bid:2.11 x 100
    Ask:2.19 x 500
    1y Target Est:2.00
    Beta:-1.43275
    Next Earnings Date:N/A
    Day's Range:2.03 - 2.15
    52wk Range:1.69 - 5.48
    Volume:477,639
    Avg Vol (3m):1,604,020
    Market Cap:203.45M
    P/E (ttm):N/A
    EPS (ttm):-0.51
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IMMUUp 1.90%203.45M
    GSKDown 2.29%95.93B
    BIIBUp 0.21%71.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):35.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :-0.33
    Quarterly EPS Est (Sep-15) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback